Abstract
Objectives
This study compares the outcomes of patients with p16+ oropharyngeal squamous cell carcinoma (OPSCC) treated with surgery followed by adjuvant radiotherapy (aRT) or chemoradiotherapy (aCRT).
Methods
From 1997 to 2009, of 376 patients with OPSCC, 97 were p16+ and eligible: 51 received aRT and 46 received aCRT. Univariate and multivariate Cox regression, and propensity score analyses were performed.
Results
The 5-year locoregional failure (LRF) and distant metastases (DM) rates for the aRT and aCRT groups were 4 versus 0 % and 10 versus 9 %, respectively. The following were associated with a worse OS and DFS on multivariate analysis: pathologic T3/T4 stage (OS p = 0.03; DFS p = 0.02), age ≥55 years (OS p = 0.02; DFS p = 0.01), and a smoking history (OS p = 0.02; DFS p = 0.04). In multivariate and propensity score analyses, aCRT did not have a significant effect on OS, DFS, and DMFS.
Conclusions
In this retrospective study of postoperative p16+, stage III–IVb OPSCC patients receiving aRT or aCRT, we did not find a benefit in OS, DFS, or DMFS with the addition of chemotherapy to IMRT. Given the predominant DM failure pattern in this surgical series, novel systemic strategies are needed. These data warrant further study.
Similar content being viewed by others
References
Ang KK, Harris J, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. New Eng J Med 363(1):24–35. doi:10.1056/NEJMoa0912217
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang K-K, Lefèbvre JL (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27(10):843–850. doi:10.1002/hed.20279
National Comprehensive Cancer Network. Head and Neck Cancers (Version 2.2014). http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 3 Oct 2014
Sinha P, Lewis JS Jr, Piccirillo JF, Kallogjeri D, Haughey BH (2012) Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 118(14):3519–3530. doi:10.1002/cncr.26671
Steiner W, Ambrosch P, Knappe M (2001) Endoscopic laser surgery of the upper aerodigestive tract: with special emphasis on cancer surgery. Thieme Medical Publishers, New York
Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH (2009) Transoral laser microsurgery (TLM) +/− adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 119(9):1709–1719. doi:10.1002/lary.20552
Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY (2012) Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 82(1):291–298. doi:10.1016/j.ijrobp.2010.10.041
Daly ME, Le Q-T, Maxim PG, Loo BW, Kaplan MJ, Fischbein NJ, Pinto H, Chang DT (2010) Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 76(5):1339–1346. doi:10.1016/j.ijrobp.2009.04.006
Haughey BH, Sinha P (2012) Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 122(S2):S13–S33
Byrd SA, Spector ME, Light E, Walline H, Komarck C, Moyer JS, Prince ME, Wolf GT, Chepeha DB, McHugh JB, Worden FP, Eisbruch A (2012) Understanding the predictive role of smoking in human papillomavirus positive advanced oropharyngeal squamous cell carcinoma. Paper presented at the 8th International Conference on Head and Neck Cancer, Toronto, ON, Canada
Eisbruch A, Harris J, Garden AS, Chao CKS, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK (2010) Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 76(5):1333–1338. doi:10.1016/j.ijrobp.2009.04.011
Garden AS, Morrison WH, Wong P-F, Tung SS, Rosenthal DI, Dong L, Mason B, Perkins GH, Ang KK (2007) Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67(2):438–444. doi:10.1016/j.ijrobp.2006.08.078
Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM (2008) Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma. Cancer 113(3):497–507. doi:10.1002/cncr.23578
Lawson JD, Otto K, Chen A, Shin DM, Davis L, Johnstone PAS (2008) Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck 30(3):327–335. doi:10.1002/hed.20694
Yao M, Nguyen T, Buatti JM, Dornfeld KJ, Tan H, Wacha J, Bayouth JE, Clamon GH, Funk GF, Smith RB, Chang K, Hoffman HT (2006) Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29(6):606–612. doi:10.1097/01.coc.0000242294.89536.d6
Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952. doi:10.1056/NEJMoa032641
Acknowledgments
The authors thank Issam El Naqa, Ph.D., and Joe O. Deasy, Ph.D., for their advice. This research project was supported in part by the Biostatistics Core of the Alvin J. Siteman Cancer Center.
Conflict of interest statement
Hiram A. Gay, Jingxia Liu, Christopher R. Spencer, James S. Lewis, Jr., Jason Diaz, Brian Nussenbaum, Jay F. Piccirillo, Daniel J. Ferraro, Tanya Wildes, Parul Sinha, Douglas R. Adkins, Bruce H. Haughey, and Wade L. Thorstad, MD., declare that they have no conflict of interest.
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hiram A. Gay and Jingxia Liu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Gay, H.A., Liu, J., Spencer, C.R. et al. Outcomes of P16 positive oropharyngeal squamous cell carcinoma treated with surgery and adjuvant IMRT. J Radiat Oncol 4, 37–46 (2015). https://doi.org/10.1007/s13566-014-0170-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-014-0170-7